If enacted, the bill mandates that the Assistant Secretary responsible for such allocations must re-evaluate the distribution of funds based on updated broadband maps within specified timelines. Specifically, 210 days following initial distribution, a recalculation will determine if the allocations need adjustment based on the latest available data. This rectification process is intended to bolster the accountability of federal funds in improving broadband access and equity across disparate regions.
Summary
SB1162, titled the 'Accurate Map for Broadband Investment Act of 2023', is designed to ensure precise broadband maps are used before any allocation of funds is executed under the Broadband Equity, Access, and Deployment Program. The bill aims to amend existing provisions in the Infrastructure Investment and Jobs Act to incorporate necessary updates and adjustments to how funds are distributed based on the most current broadband data maps. This legislative move seeks to enhance the efficacy of federal broadband investments by reducing discrepancies in mapping data that can lead to misallocation of resources.
Contention
While the bill has gained support for addressing crucial infrastructure gaps, there may be concerns about the implications of stringent reallocation processes on local entities that depend on timely funding. Critics may argue that frequent adjustments could lead to uncertainty in project planning and execution for states and municipalities, particularly in areas where broadband development is critically needed. Additionally, the bill could face scrutiny regarding the effectiveness of the updated mapping efforts and whether they truly reflect the needs of underserved populations.
A bill for an act relating to controlled substances, including certain controlled substances schedules and precursor substances reporting requirements, making penalties applicable, and including effective date provisions. (Formerly HSB 25.) Effective date: 03/28/2025.
A bill for an act relating to controlled substances, including certain controlled substances schedules and precursor substances reporting requirements, making penalties applicable, and including effective date provisions.